EGRX Historical Earnings image   This EGRX historical earnings page last updated 11/8/2022
EGRX Historical Revenue
PeriodHistorical Earnings DateGAAP
Q3 202211/7/20220.07B
Q2 20228/9/20220.07B
Q1 20225/9/20220.12B
Q4 20213/7/20220.04B
Q3 202111/9/20210.04B
Q2 20218/9/20210.05B
Q1 20215/10/20210.04B
Q4 20203/2/20210.05B
Q3 202011/2/20200.05B
Q2 20208/10/20200.04B
Q1 20205/11/20200.05B
Q4 20193/2/20200.05B
Q3 201911/12/20190.04B
Q2 20198/8/20190.06B
Q1 20195/7/20190.05B
Q4 20182/28/201956.05M
Q3 201811/1/201851.34M
Q2 20188/7/201859.30M
Q1 20185/10/201846.63M
Q4 20172/26/201846.78M
Q3 201711/8/201763.02M
Q2 20178/9/201750.11M
Q1 20175/8/201776.79M
Q4 20163/1/201781.14M
Q3 201611/9/201637.83M
Q2 20168/9/201640.92M
Q1 20165/9/201629.59M
Q4 20152/25/201618.18M
Q3 201511/11/20155.74M
Q2 20158/11/20156.00M
Q1 20155/12/201536.31M
Q4 201412/17/20142.88M
Q3 20148/11/20145.80M
Q2 20145/14/20143.22M
EGRX Historical Earnings EPS
PeriodHistorical Earnings DateAdj. EPS
Q3 202211/7/20221.120
Q2 20228/9/20221.560
Q1 20225/9/20224.040
Q4 20213/7/20220.850
Q3 202111/9/20210.560
Q2 20218/9/20210.930
Q1 20215/10/20210.240
Q4 20203/2/20210.960
Q3 202011/2/20201.170
Q2 20208/10/20200.570
Q1 20205/11/20200.840
Q4 20193/2/20200.480
Q3 201911/12/20190.260
Q2 20198/8/20190.840
Q1 20195/7/20191.010
Q4 20182/28/20191.2
Q3 201811/1/20181.18
Q2 20188/7/20180.95
Q1 20185/10/20180.53
Q4 20172/26/20181
Q3 201711/8/20171.22
Q2 20178/9/20170.49
Q1 20175/8/20171.42
Q4 20163/1/20172.69
Q3 201611/9/20160.73
Q2 20168/9/20160.8
Q1 20165/9/2016-0.06
Q4 20152/25/20160.07
Q3 201511/11/2015-0.65
Q2 20158/11/2015-0.53
Q1 20155/12/20151.31
Q4 201412/17/2014-0.91
Q3 20148/11/2014-0.21
Q2 20145/14/2014-0.36
Quotes delayed 20 minutes

Email EnvelopeFree EGRX Email Alerts:
Get Dividend Alerts
Get SEC Filing Alerts
10 Most Oversold S&P 500 Stocks
10 Most Overbought S&P 500 Stocks
10 ETFs With Stocks Insiders Are Buying
10 ETFs With Most Upside To Targets
The DividendRank Top 25
Warren Buffett Dividend Stocks
10 Cheap Dividend Stocks Under $10
10 Top DividendRank'ed Energy Stocks
The 10 Highest Yielding Preferred Stocks
The 10 Highest Yielding Preferred Stocks
The 15 Most Active S&P Call & Put Options
Eagle Pharmaceuticals (EGRX) is categorized under the Healthcare sector; to help you further research past earnings across stocks, below are some other companies in the same sector:

EHC Historical Earnings
EIGR Historical Earnings
EKSO Historical Earnings
ELAN Historical Earnings
ELDN Historical Earnings
ELEV Historical Earnings
ELOX Historical Earnings
ELYM Historical Earnings
ENDP Historical Earnings
ENOB Historical Earnings
What was the record high EGRX historical earnings result?
In terms of earnings or revenue, what is the best EGRX historical earnings result that Eagle Pharmaceuticals has ever posted, and when?

✔️Accepted answer: Within our data set, the highest EGRX historical earnings result was set in Q1 2022, when Eagle Pharmaceuticals posted results of 4.040/share. The most successful revenue quarter within our data set was Q1 2022 when Eagle Pharmaceuticals reported revenue of 0.12B.

What was the lowest Eagle Pharmaceuticals historical earnings result?
In terms of top line revenue or bottom line earnings per share, what was the lowest EGRX has reported, and when?

✔️Accepted answer: Within our data set, the lowest EGRX historical earnings result was set in Q4 2014, when Eagle Pharmaceuticals posted results of -0.91/share. The smallest revenue quarter within our data set was Q4 2014 when Eagle Pharmaceuticals reported revenue of 2.88M.

On this page we presented the EGRX historical earnings date information for Eagle Pharmaceuticals. Reviewing that EGRX Historical Earnings for the company, we see that the highest historical earnings result in our data set was in Q1 2022, when EGRX posted adjusted EPS of 4.040/share. Meanwhile the lowest EGRX historical earnings result was in Q4 2014, when EGRX posted adjusted EPS of -0.91/share. Moving to Eagle Pharmaceuticalss historical revenue numbers, the largest revenue quarter in our data set was seen in Q1 2022 when EGRX reported 0.12B in revenue, while the smallest revenue quarter was Q4 2014 when EGRX reported 2.88M in revenue.

For self directed investors doing their due diligence on EGRX or any other given stock, their research can benefit from looking into all of the Eagle Pharmaceuticals historical earnings in our data set presented side by side on one page for ease of comparison. Reviewing this historical EPS information can help when projecting future earnings per share, as well as providing important context for pondering whether the historical earnings trajectory justifies the current stock value or not. That's why we bring you HistoricalEarnings.com to make it more convenient for investors to look into Eagle Pharmaceuticals historical earnings, or the historical earnings information for any stock in our coverage universe. In your continued due diligence investigations, we hope you check out the further links included for historical PE studies, earnings surprises history as well as next earnings dates for EGRX. Thanks for visiting, and the next time you need to research EGRX historical earnings or those of another stock, we hope our site will come to your mind as your preferred historical earnings, revenue, and EPS research resource of choice.

Recommended: Funds Holding NXZ, Top Ten Hedge Funds Holding THRN, Top Ten Hedge Funds Holding ZT.

 

EGRX Historical Earnings | www.HistoricalEarnings.com | Copyright © 2020 - 2022, All Rights Reserved

Nothing in HistoricalEarnings.com is intended to be investment advice, nor does it represent the opinion of, counsel from, or recommendations by BNK Invest Inc. or any of its affiliates, subsidiaries or partners. None of the information contained herein constitutes a recommendation that any particular security, portfolio, transaction, or investment strategy is suitable for any specific person. All viewers agree that under no circumstances will BNK Invest, Inc,. its subsidiaries, partners, officers, employees, affiliates, or agents be held liable for any loss or damage caused by your reliance on information obtained. By visiting, using or viewing this site, you agree to the following Full Disclaimer & Terms of Use and Privacy Policy. Video widget and market videos powered by Market News Video. Quote and option data delayed at least 15 minutes; stock quote data powered by Ticker Technologies, and Mergent.